V. Re

First name
V.
Middle name
3rd Lo
Last name
Re
Carbonari, D. M., Saine, M. E., Newcomb, C. W., Blak, B., Roy, J. A., Haynes, K., et al. (2015). Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN). Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3844
Saine, M. E., Carbonari, D. M., Newcomb, C. W., Nezamzadeh, M. S., Haynes, K., Roy, J. A., et al. (2015). Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs. BMC Pharmacol Toxicol. http://doi.org/10.1186/s40360-015-0007-z
Saine, M. E., Gizaw, M., Carbonari, D. M., Newcomb, C. W., Roy, J. A., Cardillo, S., et al. (2017). Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4368
Lum, K. J., Newcomb, C. W., Roy, J. A., Carbonari, D. M., Saine, M. E., Cardillo, S., et al. (2017). Evaluation of methods to estimate missing days\textquoteright supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN). Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-016-2148-4
Saine, M. E., Carbonari, D. M., Newcomb, C. W., Gallagher, A. M., Blak, B. T., Roy, J. A., et al. (2019). Concordance of hospitalizations between Clinical Practice Research Datalink and linked Hospital Episode Statistics among patients treated with oral antidiabetic therapies. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4853